About Us
Targeting inflammation
Management Team
Board of Directors
Corporate Governance
Development
INV102 (nadolol)
INV103 (ala-Cpn10)
INV104 (zafirlukast)
Investors
Annual Reports
Financial Reports
Investor Presentations
Analyst Coverage
News & Media
Market Announcements
Investor and Media Contact
Clinical Trials
Chronic Bronchitis
Asthma
Systemic Lupus Erythematosus
Contact
ASX:IVX
Home
›
2014
›
February
Monthly Archives:
February 2014
February 28, 2014
Release of securities from escrow
February 26, 2014
Invion announces Rights Issue Entitlement Offer
February 25, 2014
Appendix 4D and Financial Report for the half year to 31 December 2013
February 21, 2014
Dr Greg Collier discusses 3M collaboration with BRR
February 21, 2014
Completion of $5M Placement; intention to conduct $2M Rights Issue. Capital to support pipeline and 3M collaboration
February 19, 2014
Collaboration with 3M Drug Delivery Systems on inhaled INV102 & INV104
February 19, 2014
Request for trading halt
Latest Releases
Appendix 4C – March 2017 Quarter
Invion announces strategic alliance
Appendix 4D and Financial Report for the half year to 31 December 2016
Appendix 4C (quarterly cashflow statement) for the December quarter
Presentation to Shareholders, 2016 AGM
News & Media Archive
April 2017
February 2017
January 2017
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
News & Media
Analyst Coverage
Annual Review
ASX Releases
Financial Reports
Presentations
